Leading Investment Newsletter Ranks GreenGro Technologies as 10th Most Attractive Stock to Own Out of List of 30 Other Cannabis Securities

ANAHEIM, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- GreenGro Technologies, Inc. (OTC: GRNH), an established provider of eco-friendly green technologies, today announced that a leading independent investment newsletter, www.investorplace.com, ranked GreenGro Technologies, Inc. as the 10^th most attractive cannabis stock to own heading into 2019.  The publication’s rationale for its ranking was primarily due to the relative success of the Company’s hydroponic greenhouse subsidiary.  The newsletter noted that “…As the American public becomes increasingly favorable to marijuana initiatives, demand for advanced grow rooms should skyrocket.  In addition, the company specializes in other turn-key facility solutions.”  The newsletter concluded by saying “….GRNH appears to have found a bottom…..we could see GreenGro stage a recovery rally later this year.”

Following is a Complete List of The Top 10 List as Published by Investorplace

“Being ranked with such heavyweights as AmeriCann and Aurora Cannabis is by far one of GreenGro’s greatest single milestones since becoming a public company,” said James Haas, Chairman and CEO of GreenGro Technologies.  “However, it wasn’t through sheer luck but rather intensive research and development, a certain tenacity to succeed that instills across all our employees and, of course, a loyal and longstanding consumer base.  Although the newsletter highlighted our state-of-the-art greenhouses, I am excited to shortly be announcing what will mark the second and possibly faster growing segment of our business, our highly anticipated launch into the CBD market,” concluded Mr. Haas.

Company’s Expected Launch into the CBD Market

Cannabidiol, or CBD, is a component of the marijuana plant. Unlike THC, CBD cannot give you a sense of euphoria or make you intoxicated.  What it can do, however, is provide anti-inflammatory, analgesic, anti-nausea and anti-seizure effects, according to industry experts.  While THC acts on certain cannabinoid receptors found in the brain and central nervous system, CBD works throughout the body.  GreenGro’s strategy all along was to allow the heavyweights, such as GW Pharmaceuticals and Insys Therapeutics, Inc. to spend the millions of research and development dollars it did not have to create the market for smaller yet more agile players such as GreenGro Technologies.  The Company expects to update investors on its latest developments in this arena very shortly.

To be added to Gala Pharmaceutical’s investor lists, please contact Bill Miller at 844-565-5665 or via email at bmiller@irpartnersinc.com.

Or like our Facebook page @    
https://www.facebook.com/gala-pharmaceuticals-147596665868456

About GreenGro Technologies
GreenGro Technologies (GRNH) is a provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small- and large-scale commercial clients. GreenGro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors. The Company’s website at www.greengrotech.com offers regular updates including educational videos, projects updates, recipes and nutritional information, and where to find the Company’s products.

Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve several risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.

Investor/Media Contact: 
Bill Miller 
Investor Relations Partners 
bmiller@irpartnersinc.com 
www.irpartnersinc.com
Phone: 844-565-5665